TIPS with bare stents and covered stents for the treatment of portal hypertension:analysis of its long-term efficacy
10.3969/j.issn.1008-794X.2024.03.013
- VernacularTitle:裸支架联合覆膜支架行经颈静脉肝内门体静脉分流术治疗门静脉高压症远期效果
- Author:
Shengli YANG
1
;
Linqiang LAI
;
Jingjing SONG
;
Dengke ZHANG
;
Zhongwei ZHAO
;
Jianfei TU
;
Jiansong JI
;
Yingjun BAO
;
Junpeng GU
;
Weixin REN
Author Information
1. 323000 浙江丽水 丽水市中心医院(温州医科大学第五附属医院)介入治疗中心
- Keywords:
portal hypertension;
stent;
long-term efficacy;
survival rate
- From:
Journal of Interventional Radiology
2024;33(3):295-299
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the long-term efficacy of transjugular intrahepatic portosystemic shunt(TIPS)with bare stents and Fluency covered stents in the treatment of portal hypertension,and to discuss its clinical value.Methods The clinical data of 29 patients with intractable ascites or esophagogastric fundus varices rupture and hemorrhage caused by cirrhotic portal hypertension,who received TIPS with bare stents and covered stents at the First Affiliated Hospital of Xinjiang Medical University of China(25 patients)and the Lishui Municipal Central Hospital of China(4 patients)between August 2012 and December 2017,were retrospectively analyzed.The patients were regularly followed up to check the survival status.The postoperative cumulative shunt patency rate and cumulative survival rate of the patients were analyzed by Kaplan-Meier method.Results The technical success rate of TIPS was 100％.The mean portal vein pressure was decreased from preoperative(40.21±3.24)cmH2O to postoperative(24.55±3.55)cmH2O(P＜0.05).The patients were followed up for 5.1-10.5 years.The postoperative 1-,3-,5-,7-year primary cumulative patency rates of the shunt were 89.7％,75.9％,75.9％ and 52.5％,respectively.The postoperative 5-,7-,9-and 10-year cumulative survival rates were 100％,66.9％,66.9％ and 33.4％,respectively.The incidence of hepatic encephalopathy was 13.8％(4/29).Conclusion Using bare stents combined with Fluency covered stents for TIPS is clinically safe and effective in the treatment of portal hypertension.This technique carries higher long-term shunt patency rate and low incidence of hepatic encephalopathy.Therefore,it can be used as a substitute for Viatorr stent when necessary.(J Intervent Radiol,2024,33:295-299)
